Reply to "Post-COVID 19 neurological syndrome: A new risk factor that modifies the prognosis of patients with dementia"

Alzheimers Dement. 2022 Mar;18(3):544. doi: 10.1002/alz.12460. Epub 2022 Jan 3.

Authors

Pamela B Davis¹, QuanQiu Wang², Rong Xu²

Affiliations

¹ Center for Community Health Integration, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.
² Center for Artificial Intelligence in Drug Discovery, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.

No abstract available

Publication types

Letter
Comment

MeSH terms

COVID-19*
Dementia*
Humans
Prognosis
Risk Factors
Syndrome

Grants and funding